Financhill
Back

Biosyent Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Buy
62

RX.V
Biosyent

Last Price:
11.9800
Seasonality Move:
24.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Biosyent Price Quote

$11.9800

Biosyent Key Stats

Buy
62
Biosyent (RX.V) is a Buy
Day range:
$11.3200 - $11.9800
52-week range:
$8.2400 - $11.7400
Dividend yield:
1.55%
P/E ratio:
21.86
P/S ratio:
3.99
P/B ratio:
3.6%
Volume:
1.5K
Avg. volume:
10.1K
1-year change:
36.91%
Market cap:
$134.6M
Revenue:
$31.6M
EPS:
$0.6

How Much Does Biosyent Make?

  • How Much Are Biosyent's Sales Annually?
    RX.V Revenues are $31.6M
  • How Much Profit Does Biosyent's Make A Year?
    RX.V net income is $6.5M

Is Biosyent Growing As A Company?

  • What Is Biosyent's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Biosyent's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Biosyent Stock Price Performance

  • Did Biosyent Stock Go Up Last Month?
    Biosyent share price went up by 7.93% last month
  • Did RX.V's Share Price Rise Over The Last Year?
    RX.V share price rose by 36.91% over the past 1 year

What Is Biosyent 52-Week High & Low?

  • What Is Biosyent’s 52-Week High Share Price?
    Biosyent has traded as high as $11.7400 over the past 52 weeks
  • What Is Biosyent’s 52-Week Low Share Price?
    Biosyent has traded as low as $8.2400 over the past 52 weeks

Biosyent Price To Free Cash Flow

  • Is Biosyent Stock Overvalued?
    Biosyent is trading at a price to free cash flow ratio of 70.99
  • Is Biosyent Stock Undervalued?
    Biosyent EV to Free Cash Flow ratio is 60.53
  • What Is Biosyent’s Price Earnings Growth Ratio?
    RX.V PEG ratio is 1.08
  • Is Biosyent Trading At A Premium To Earnings?
    Biosyent EV to EBIT ratio is 12.44

Is It Risky To Buy Biosyent?

  • How Much Debt Does Biosyent Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Biosyent Have?
    Cash and short term investments quarterly total is $17.1M
  • What Is Biosyent’s Book Value Per Share?
    Book value per share is 3.22

Is Biosyent Cash Flow Positive?

  • What Is RX.V Cash Flow From Operations?
    Cash flow from operations (TTM) is $6.7M
  • What Is Biosyent’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$4.9M
  • What Is Biosyent’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.5M

Biosyent Return On Invested Capital

  • Is Management Doing A Good Job?
    RX.V return on invested capital is 20.12%
  • What Is Biosyent Return On Assets?
    ROA measures how assets are converting to revenues and is 16.93%
  • What Is RX.V Return On Equity?
    ROE is a measure of profitability and is 20.12%

Biosyent Earnings Date & Stock Price

  • What Is Biosyent's Stock Price Today?
    A single share of RX.V can be purchased today for 11.9800
  • What Is Biosyent’s Stock Symbol?
    Biosyent trades on the tsxv under the ticker symbol: RX.V
  • When Is Biosyent’s Next Earnings Date?
    The next quarterly earnings date for Biosyent is scheduled on March 13, 2025
  • When Is RX.V's next ex-dividend date?
    Biosyent's next ex-dividend date is November 29, 2024
  • How To Buy Biosyent Stock?
    You can buy Biosyent shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biosyent Competitors

  • Who Are Biosyent's Competitors?
    Below is a list of companies who compete with Biosyent or are related in some way:

Biosyent Dividend Yield

  • What Is RX.V Dividend Yield?
    Biosyent’s dividend yield currently is 1.55%
  • What Is Biosyent’s Payout Ratio?
    Biosyent’s payout ratio is 28.69%
  • When Did Biosyent Last Pay A Dividend?
    The latest dividend pay date is December 14, 2024
  • What Is Biosyent’s Dividend Per Share?
    Biosyent pays a dividend of $0.0450 per share

Biosyent Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 7.72% 6.18%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.7500
Downside from Last Price: -1.92%

Major Shareholders

  • How many RX.V shares are owned by institutional investors?
    389.8K RX.V shares are owned by institutional investors
  • How many RX.V shares are owned by insiders?
    0 RX.V shares are owned by insiders